Robert Edward Sosnowski - Net Worth and Insider Trading
Robert Edward Sosnowski Net Worth
The estimated net worth of Robert Edward Sosnowski is at least $0 dollars as of 2024-09-20. Robert Edward Sosnowski is the VP, Sales & Marketing of Cyclacel Pharmaceuticals Inc and owns about 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) stock worth over $0. Details can be seen in Robert Edward Sosnowski's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Edward Sosnowski has not made any transactions after 2010-05-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Edward Sosnowski
Robert Edward Sosnowski Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Edward Sosnowski owns 1 companies in total, including Cyclacel Pharmaceuticals Inc (CYCC) .
Click here to see the complete history of Robert Edward Sosnowski’s form 4 insider trades.
Insider Ownership Summary of Robert Edward Sosnowski
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals Inc | 2011-12-06 | VP & Marketing & Sales |
Robert Edward Sosnowski Latest Holdings Summary
Robert Edward Sosnowski currently owns a total of 1 stock. Robert Edward Sosnowski owns 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) as of May 4, 2010, with a value of $0.
Latest Holdings of Robert Edward Sosnowski
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals Inc | 2010-05-04 | 0 | 1.06 | 0 |
Holding Weightings of Robert Edward Sosnowski
Robert Edward Sosnowski Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Edward Sosnowski has made a total of 0 transactions in Cyclacel Pharmaceuticals Inc (CYCC) over the past 5 years. The most-recent trade in Cyclacel Pharmaceuticals Inc is the sale of 0 shares on May 4, 2010, which brought Robert Edward Sosnowski around $25,000.
Insider Trading History of Robert Edward Sosnowski
- 1
Robert Edward Sosnowski Trading Performance
Robert Edward Sosnowski Ownership Network
Robert Edward Sosnowski Owned Company Details
What does Cyclacel Pharmaceuticals Inc do?
Who are the key executives at Cyclacel Pharmaceuticals Inc?
Robert Edward Sosnowski is the VP & Marketing & Sales of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & E.V.P. & Finance & C.O.O. Paul Mcbarron , director & President & C.E.O. Spiro Rombotis , and Chief Medical Officer Mark Kirschbaum .
Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary
Over the past 18 months, Robert Edward Sosnowski made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .
In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.
Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclacel Pharmaceuticals Inc Insider Transactions
Robert Edward Sosnowski Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Edward Sosnowski. You might contact Robert Edward Sosnowski via mailing address: C/o Cyclacel Pharmaceuticals, Inc., 200 Connell Drive, Suite 1500, Berkeley Heights Nj 07922.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
